Targeted protein degradation: A promise for undruggable proteins

KTG Samarasinghe, CM Crews - Cell chemical biology, 2021 - cell.com
Summary Protein homeostasis, or" proteostasis," is indispensable for a balanced, healthy
environment within the cell. However, when natural proteostasis mechanisms are …

Osteosarcoma mechanobiology and therapeutic targets

Z Shoaib, TM Fan… - British journal of …, 2022 - Wiley Online Library
Osteosarcoma is one of the most common primary tumours of the bone, with a 5‐year
survival rate of less than 20% after the development of metastases. Osteosarcoma is highly …

Recent and ongoing research into metastatic osteosarcoma treatments

MA Harris, CJ Hawkins - International Journal of Molecular Sciences, 2022 - mdpi.com
The survival rate for metastatic osteosarcoma has not improved for several decades, since
the introduction and refinement of chemotherapy as a treatment in addition to surgery. Over …

Probing the potential of defense response-associated genes for predicting the progression, prognosis, and immune microenvironment of osteosarcoma

L Huang, F Sun, Z Liu, W Jin, Y Zhang, J Chen… - Cancers, 2023 - mdpi.com
Simple Summary Osteosarcoma (OS) is the most common primary orthopedic malignancy
and typically affects children and young adults. Its lesions often metastasize to distant sites …

Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma

CE Lietz, ET Newman, AD Kelly, DH Xiang… - Communications …, 2022 - nature.com
Aberrant methylation of genomic DNA has been reported in many cancers. Specific DNA
methylation patterns have been shown to provide clinically useful prognostic information …

What's new in bone forming tumours of the skeleton?

N Franceschini, SW Lam, AM Cleton-Jansen… - Virchows Archiv, 2020 - Springer
Bone tumours are difficult to diagnose and treat, as they are rare and over 60 different
subtypes are recognised. The emergence of next-generation sequencing has partly …

Engaging plasticity: Differentiation therapy in solid tumors

N Bar-Hai, D Ishay-Ronen - Frontiers in Pharmacology, 2022 - frontiersin.org
Cancer is a systemic heterogeneous disease that can undergo several rounds of latency
and activation. Tumor progression evolves by increasing diversity, adaptation to signals from …

Advances in differentiation therapy for osteosarcoma

Y Chen, J Cao, N Zhang, B Yang, Q He, X Shao… - Drug discovery today, 2020 - Elsevier
Highlights•Osteosarcoma is a disease resulting from osteogenic differentiation
defects.•Differentiation therapy for osteosarcoma has received extensive attention.•Various …

Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment

T Wang, J Jin, C Qian, J Lou, J Lin, A Xu, K Xia… - Cancer Cell …, 2021 - Springer
As the essential sexual hormone, estrogen and its receptor has been proved to participate in
the regulation of autoimmunity diseases and anti-tumor immunity. The adjustment of tumor …

The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma

M Ruh, MP Stemmler, I Frisch, K Fuchs… - The Journal of …, 2021 - Wiley Online Library
Osteosarcoma is an often‐fatal mesenchyme‐derived malignancy in children and young
adults. Overexpression of EMT‐transcription factors (EMT‐TFs) has been associated with …